Dr. Gerds is an Associate Professor of Medicine and Deputy Director for Clinical Re-search at the Cleveland Clinic Taussig Institute. He serves as the Medical Director of the Clinical Research Office for the Case Comprehensive Cancer Center. He is also the Edi-tor-in-Chief of ASH Clinical News, and is the Chair of the NCCN MPN guidelines panel. Dr. Gerds’ clinical and research interests focus on optimizing current treatments, and de-veloping new therapies for patients with myeloproliferative disorders and other myeloid neoplasia.